Tag: Cardiovascular
-
When Better Blood Sugar Comes at the Heart’s Expense
Favourable glycemic responses do not preclude the development of a more atherogenic lipid profile.
-
When One Organ Leads the Decline
Biological age is better conceptualized as a constellation of organ clocks rather than a single composite index.
-
The Long Game of Going Easy
The case for Zone 2 is ultimately a case for longevity through sustainable, accumulable, low-risk training.
-
When Mastery of Movement Meets Mastery of Metabolism
Mastery of movement must be paralleled by mastery of metabolism.
-
The Mini Polypill in Your Kitchen Drawer
Garlic is not a single-target agent but rather a multi-component, multi-pathway intervention that functions as a ‘mini-polypill’.
-
Comparing BPC-157 TB-500 and GHK-Cu for Tissue Repair and Clinical Selection
BPC-157, thymosin beta-4, and GHK-Cu are not competing agents but complementary tools, each with distinct mechanisms, target tissue strengths, evidence profiles, and regulatory positions.
-
Regenerative Peptides and the Promise of Tissue Repair
BPC-157, thymosin beta-4, and GHK-Cu represent a mechanistically distinct category of regenerative peptides with compelling preclinical evidence and plausible clinical applications.
-
How GLP-1 Receptor Agonists Transformed the Treatment of Obesity and Diabetes
The GLP-1 receptor agonist and multi-receptor agonist class represents the most important pharmacological advance in metabolic medicine in the 21st century.